Odonkor Gloria N, Kang Hyeun Ah, Lu Ange, Mignacca Robert C, Chang Alicia, Lawson Kenneth A
College of Pharmacy, The University of Texas at Austin, Austin, TX 78712, USA.
Children's Blood and Cancer Center at Dell Children's Hospital, Austin, TX 78723, USA.
Healthcare (Basel). 2025 Jun 25;13(13):1519. doi: 10.3390/healthcare13131519.
Children with sickle cell disease (SCD) often experience limited access to care, contributing to poor health outcomes. Patient-level predictors and outcomes associated with telehealth use among Medicaid-enrolled children with SCD remain unknown. This study aims to (1) analyze telehealth trends before and during the pandemic (March 2020-March 2022), (2) identify patient-level predictors of telehealth use, (3) assess its association with care continuity and health outcomes, and (4) identify physician specialties involved in telehealth visits. Using Texas Medicaid claims (March 2017-March 2022), we conducted a retrospective analysis of children aged 1-18 with ≥3 SCD-related claims. Monthly trends in outpatient visits (in-person and telehealth) were visualized from March 2019 to March 2022. Multivariable regression models examined predictors of telehealth use and associations with ≥10 hydroxyurea fills, emergency department (ED) visits, and hospitalizations, adjusting for age, sex, regions with SCD clinics, and prior healthcare utilization. : Among 903 included patients (mean [SD] age = 10.4 [4.1], 52.6% male), 59.4% had ≥1 telehealth visits between March 2019 and March 2022. Telehealth use peaked between March 2020 and May 2020, then gradually declined. Children with ≥10 SCD-related outpatient visits 1 year before the lockdown (March 2019-February 2020) had 77.4% higher odds of using telehealth compared to those with 0-4 visits (OR = 1.774, 95% CI = 1.281-2.457, = 0.0006), while controlling for sociodemographic characteristics. However, SCD-related telehealth use during the pandemic was not associated with either ≥10 hydroxyurea fills or reduced ED visits. Prior healthcare utilization remained a strong predictor of both outcomes. The majority of telehealth visits were conducted at multispecialty clinics (74%). Telehealth use surged early in the pandemic but later declined among Texas Medicaid-enrolled children with SCD. Children with high healthcare needs adopted telehealth, but this did not impact care continuity or extensive healthcare utilization. While maintaining telehealth access, other measures should be implemented to improve access and outcomes for this vulnerable population.
镰状细胞病(SCD)患儿往往难以获得充分的医疗服务,导致健康状况不佳。对于参加医疗补助计划的SCD患儿,与远程医疗使用相关的患者层面预测因素和结果仍不明确。本研究旨在:(1)分析疫情前及疫情期间(2020年3月至2022年3月)的远程医疗趋势;(2)确定远程医疗使用的患者层面预测因素;(3)评估其与医疗连续性和健康结果的关联;(4)确定参与远程医疗就诊的医生专业。利用德克萨斯州医疗补助计划理赔数据(2017年3月至2022年3月),我们对1至18岁、有≥3次与SCD相关理赔的儿童进行了回顾性分析。呈现了2019年3月至2022年3月门诊就诊(面对面和远程医疗)的月度趋势。多变量回归模型检验了远程医疗使用的预测因素以及与≥10次羟基脲配药、急诊就诊和住院的关联,并对年龄、性别、设有SCD诊所的地区以及先前的医疗服务利用情况进行了调整。在903名纳入研究的患者中(平均[标准差]年龄 = 10.4[4.1],52.6%为男性),59.4%在2019年3月至2022年3月期间有≥1次远程医疗就诊。远程医疗使用在2020年3月至2020年5月达到峰值,随后逐渐下降。在封锁前1年(2019年3月至2020年2月)有≥10次与SCD相关门诊就诊的儿童使用远程医疗的几率比有0 - 4次就诊的儿童高77.4%(比值比 = 1.774,95%置信区间 = 1.281 - 2.457,P = 0.0006),同时对社会人口统计学特征进行了控制。然而,疫情期间与SCD相关的远程医疗使用与≥10次羟基脲配药或急诊就诊减少均无关联。先前的医疗服务利用情况仍然是这两个结果的有力预测因素。大多数远程医疗就诊是在多专科诊所进行的(74%)。在德克萨斯州参加医疗补助计划的SCD患儿中,远程医疗使用在疫情早期激增,但后来有所下降。有高医疗需求的儿童采用了远程医疗,但这并未影响医疗连续性或大量医疗服务利用。在维持远程医疗服务可及性的同时,应采取其他措施来改善这一弱势群体的医疗可及性和健康结果。